Clinical Trials List
Protocol NumberACE-Pan tumor-02
2022-02-01 - 2022-04-06
Phase II
Recruiting1
Terminated2
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/19
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chia-Jui Yen Division of Hematology & Oncology
- Chien-Chung Lin Division of General Internal Medicine
- Wu-Chou Su Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Po-Lan Su Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Kun-Huei Yeh Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- 林季宏 Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
9 participants
-
Global
265 participants
